Yong-ming Chen
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 05, 2026
Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trial.
Journal: Med (New York, N.Y.)
Published: April 02, 2026
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: July 30, 2024
Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 03, 2024
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Journal: Nature medicine
Published: January 08, 2024
Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system.
Journal: World journal of gastroenterology
Published: October 31, 2023
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Journal: Nature medicine
Published: June 20, 2023
Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis.
Journal: Biomedicines
Published: May 16, 2023
The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma.
Journal: Genome medicine
Published: September 24, 2020
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials.
Journal: BMC cancer
Published: August 08, 2019
Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.
Journal: Journal of Cancer
Published: January 28, 2019
Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 12, 2018
Last Updated: 09/26/2026